Susan L. Tucker

21.2k total citations · 3 hit papers
224 papers, 16.1k citations indexed

About

Susan L. Tucker is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Susan L. Tucker has authored 224 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pulmonary and Respiratory Medicine, 71 papers in Radiation and 67 papers in Oncology. Recurrent topics in Susan L. Tucker's work include Advanced Radiotherapy Techniques (71 papers), Effects of Radiation Exposure (37 papers) and Breast Cancer Treatment Studies (34 papers). Susan L. Tucker is often cited by papers focused on Advanced Radiotherapy Techniques (71 papers), Effects of Radiation Exposure (37 papers) and Breast Cancer Treatment Studies (34 papers). Susan L. Tucker collaborates with scholars based in United States, China and Sweden. Susan L. Tucker's co-authors include Lei Dong, James D. Cox, Zhongxing Liao, Radhe Mohan, Deborah A. Kuban, Thomas A. Buchholz, Howard D. Thames, George Starkschall, Gabriel N. Hortobágyi and Eugene Huang and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Susan L. Tucker

223 papers receiving 15.7k citations

Hit Papers

Long-Term Results of the M. D. Anderson Randomized Dose-E... 2004 2026 2011 2018 2007 2004 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan L. Tucker United States 72 7.5k 5.5k 4.7k 4.2k 3.0k 224 16.1k
Howard D. Thames United States 65 8.6k 1.2× 5.0k 0.9× 5.3k 1.1× 3.2k 0.8× 2.9k 1.0× 298 16.4k
Roberto Orecchia Italy 60 5.2k 0.7× 4.7k 0.8× 3.3k 0.7× 3.8k 0.9× 4.2k 1.4× 515 14.1k
Herman D. Suit United States 74 10.7k 1.4× 3.6k 0.6× 3.6k 0.8× 5.4k 1.3× 1.9k 0.6× 324 17.7k
Steven E. Schild United States 66 12.1k 1.6× 3.1k 0.6× 2.5k 0.5× 8.0k 1.9× 2.0k 0.7× 637 21.9k
Harry Bartelink Netherlands 74 5.4k 0.7× 3.8k 0.7× 3.9k 0.8× 7.1k 1.7× 9.1k 3.0× 270 20.5k
Allen S. Lichter United States 56 4.0k 0.5× 3.3k 0.6× 2.7k 0.6× 3.7k 0.9× 3.8k 1.2× 159 11.2k
David P. Dearnaley United Kingdom 73 11.3k 1.5× 4.6k 0.8× 5.0k 1.1× 3.7k 0.9× 1.9k 0.6× 416 18.4k
Michael Flentje Germany 60 5.2k 0.7× 5.3k 0.9× 4.5k 1.0× 1.9k 0.5× 1.3k 0.4× 370 11.7k
Lena Specht Denmark 63 5.2k 0.7× 2.6k 0.5× 4.0k 0.8× 4.9k 1.2× 1.6k 0.5× 315 16.3k
M. Bolla France 50 16.6k 2.2× 3.3k 0.6× 3.2k 0.7× 4.6k 1.1× 2.3k 0.8× 231 22.9k

Countries citing papers authored by Susan L. Tucker

Since Specialization
Citations

This map shows the geographic impact of Susan L. Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Tucker more than expected).

Fields of papers citing papers by Susan L. Tucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Tucker. The network helps show where Susan L. Tucker may publish in the future.

Co-authorship network of co-authors of Susan L. Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Tucker. A scholar is included among the top collaborators of Susan L. Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Tucker. Susan L. Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llarena, Natalia C., et al.. (2015). Impact of Fertility Concerns on Tamoxifen Initiation and Persistence. JNCI Journal of the National Cancer Institute. 107(10). djv202–djv202. 99 indexed citations
2.
Tucker, Susan L., Kshipra M. Gharpure, Shelley M. Herbrich, et al.. (2014). Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 20(12). 3280–3288. 68 indexed citations
3.
Sulman, Erik P., Anuja Jhingran, Susan L. Tucker, et al.. (2014). Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer. International Journal of Radiation Oncology*Biology*Physics. 88(2). 357–362. 47 indexed citations
4.
Park, Peter C., J Cheung, X Zhu, et al.. (2013). Statistical Assessment of Proton Treatment Plans Under Setup and Range Uncertainties. International Journal of Radiation Oncology*Biology*Physics. 86(5). 1007–1013. 55 indexed citations
5.
Tucker, Susan L., et al.. (2013). Predicting Pneumonitis Risk: A Dosimetric Alternative to Mean Lung Dose. International Journal of Radiation Oncology*Biology*Physics. 85(2). 522–527. 26 indexed citations
6.
Gomez, Daniel R., Susan L. Tucker, Mary K. Martel, et al.. (2012). Predictors of High-grade Esophagitis After Definitive Three-dimensional Conformal Therapy, Intensity-modulated Radiation Therapy, or Proton Beam Therapy for Non-small cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 84(4). 1010–1016. 42 indexed citations
7.
Akay, Catherine L., Funda Meric‐Bernstam, Kelly K. Hunt, et al.. (2011). Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 19(3). 901–907. 39 indexed citations
8.
Akli, Saïd, Tuyen Bui, Hannah F. Wingate, et al.. (2010). Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors. Clinical Cancer Research. 16(4). 1179–1190. 41 indexed citations
9.
Albert, Jeffrey M., Ana M. González-Angulo, Merih Güray, et al.. (2010). Estrogen/Progesterone Receptor Negativity and HER2 Positivity Predict Locoregional Recurrence in Patients With T1a,bN0 Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1296–1302. 58 indexed citations
10.
Gilcrease, Michael Z., Wendy A. Woodward, Marlo Nicolas, et al.. (2009). Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer. The American Journal of Surgical Pathology. 33(5). 759–767. 78 indexed citations
11.
Nelson, Christopher, Peter Balter, Rodolfo C. Morice, et al.. (2008). A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. Journal of Applied Clinical Medical Physics. 9(4). 110–122. 4 indexed citations
12.
Akli, Saïd, Carolyn S. Van Pelt, Tuyen Bui, et al.. (2007). Overexpression of the Low Molecular Weight Cyclin E in Transgenic Mice Induces Metastatic Mammary Carcinomas through the Disruption of the ARF-p53 Pathway. Cancer Research. 67(15). 7212–7222. 61 indexed citations
13.
Geara, Fady, Elie Nasr, Susan L. Tucker, et al.. (2007). Breast Cancer Patients With 10 or More Involved Axillary Lymph Nodes Treated by Multimodality Therapy: Influence of Clinical Presentation on Outcome. International Journal of Radiation Oncology*Biology*Physics. 68(2). 364–369. 6 indexed citations
14.
Cheung, Rex, Susan L. Tucker, & Deborah A. Kuban. (2006). First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival. International Journal of Radiation Oncology*Biology*Physics. 66(1). 20–24. 22 indexed citations
15.
Akli, Saïd, Asha S. Multani, Hannah F. Wingate, et al.. (2004). Tumor-Specific Low Molecular Weight Forms of Cyclin E Induce Genomic Instability and Resistance to p21, p27, and Antiestrogens in Breast Cancer. Cancer Research. 64(9). 3198–3208. 117 indexed citations
16.
Barker, Jerry L., Adam S. Garden, K. Kian Ang, et al.. (2004). Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. International Journal of Radiation Oncology*Biology*Physics. 59(4). 960–970. 581 indexed citations breakdown →
17.
Forster, Kenneth, Craig Stevens, C. Bloch, et al.. (2004). Dosimetric benefits of respiratory gating: a preliminary study. Journal of Applied Clinical Medical Physics. 5(1). 16–24. 33 indexed citations
18.
Rosen, Isaac I., John A. Antolak, George Starkschall, et al.. (2001). Correlation between Lung Fibrosis and Radiation Therapy Dose after Concurrent Radiation Therapy and Chemotherapy for Limited Small Cell Lung Cancer. Radiology. 221(3). 614–622. 45 indexed citations
19.
Félix, Ana, Adel K. El‐Naggar, Michael F. Press, et al.. (1996). Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Human Pathology. 27(6). 561–566. 70 indexed citations
20.
Thames, Howard D., et al.. (1986). Direct Analysis of Quantal Radiation Response Data. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 49(6). 999–1009. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026